BNP Paribas Financial Markets
NVCR icon

BNP Paribas Financial Markets’s NovoCure NVCR Stock Holding History

BNP Paribas Financial Markets’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.72M Buy
708,293
+464,221
+190% +$5.8M ﹤0.01% 1717
2025
Q4 		$3.16M Buy
244,072
+175,712
+257% +$2.26M ﹤0.01% 2332
2025
Q3 		$883K Buy
68,360
+39,079
+133% +$522K ﹤0.01% 3206
2025
Q2 		$521K Sell
29,281
-14,414
-33% -$251K ﹤0.01% 3300
2025
Q1 		$779K Buy
43,695
+15,140
+53% +$344K ﹤0.01% 2942
2024
Q4 		$851K Sell
28,555
-147,371
-84% -$3.12M ﹤0.01% 2929
2024
Q3 		$2.75M Sell
175,926
-56,898
-24% -$1.03M ﹤0.01% 1870
2024
Q2 		$3.99M Buy
232,824
+195,645
+526% +$3.44M ﹤0.01% 1530
2024
Q1 		$581K Sell
37,179
-113,235
-75% -$1.67M ﹤0.01% 2767
2023
Q4 		$2.25M Sell
150,414
-22,127
-13% -$296K ﹤0.01% 1884
2023
Q3 		$2.79M Buy
172,541
+39,956
+30% +$1.15M ﹤0.01% 1662
2023
Q2 		$5.5M Buy
132,585
+100,235
+310% +$6.22M 0.01% 1191
2023
Q1 		$1.95M Buy
32,350
+4,871
+18% +$389K ﹤0.01% 1834
2022
Q4 		$2.02M Sell
27,479
-8,912
-24% -$671K ﹤0.01% 1760
2022
Q3 		$2.76M Sell
36,391
-67,580
-65% -$5.27M ﹤0.01% 1714
2022
Q2 		$7.23M Buy
103,971
+39,373
+61% +$2.97M 0.01% 1062
2022
Q1 		$5.35M Sell
64,598
-18,570
-22% -$1.37M 0.01% 1269
2021
Q4 		$6.24M Buy
83,168
+56,584
+213% +$5.68M 0.01% 1219
2021
Q3 		$3.09M Sell
26,584
-3,971
-13% -$600K ﹤0.01% 1609
2021
Q2 		$6.78M Buy
30,555
+14,446
+90% +$2.81M 0.01% 1141
2021
Q1 		$2.13M Sell
16,109
-7,741
-32% -$1.22M ﹤0.01% 1635
2020
Q4 		$4.13M Buy
23,850
+18,111
+316% +$2.48M 0.01% 1242
2020
Q3 		$639K Sell
5,739
-58,673
-91% -$4.69M ﹤0.01% 2068
2020
Q2 		$3.82M Buy
64,412
+29,880
+87% +$1.97M 0.01% 1186
2020
Q1 		$2.33M Buy
34,532
+1,960
+6% +$155K ﹤0.01% 1395
2019
Q4 		$2.74M Buy
32,572
+16,916
+108% +$1.37M 0.01% 1524
2019
Q3 		$1.17M Buy
15,656
+5,620
+56% +$449K ﹤0.01% 1773
2019
Q2 		$635K Sell
10,036
-6,968
-41% -$353K ﹤0.01% 1899
2019
Q1 		$819K Buy
17,004
+15,330
+916% +$738K ﹤0.01% 1802
2018
Q4 		$56K Sell
1,674
-2,382
-59% -$87.1K ﹤0.01% 2659
2018
Q3 		$213K Buy
4,056
+434
+12% +$17.3K ﹤0.01% 2376
2018
Q2 		$113K Sell
3,622
-8,773
-71% -$244K ﹤0.01% 2727
2018
Q1 		$270K Buy
12,395
+395
+3% +$8.5K ﹤0.01% 2621
2017
Q4 		$242K Buy
12,000
+5,146
+75% +$99.1K ﹤0.01% 2868
2017
Q3 		$136K Sell
6,854
-375
-5% -$7.37K ﹤0.01% 2634
2017
Q2 		$125K Buy
7,229
+6,419
+792% +$82.9K ﹤0.01% 2715
2017
Q1 		$6.56K Sell
810
-712
-47% -$5.14K ﹤0.01% 3256
2016
Q4 		$11.9K Sell
1,522
-2,666
-64% -$21.4K ﹤0.01% 3376
2016
Q3 		$35.8K Buy
4,188
+2,190
+110% +$20K ﹤0.01% 2584
2016
Q2 		$23.3K Buy
1,998
+1,988
+19,880% +$24.9K ﹤0.01% 2530
2016
Q1 		$145 Sell
10
-1,508
-99% -$21.6K ﹤0.01% 2611
2015
Q4 		$33.9K Buy
+1,518
New +$36.3K ﹤0.01% 3063

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

BNP Paribas Financial Markets's NVCR Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its NovoCure (NVCR) stake by 190% in Q1 2026, buying an estimated $5.8M and bringing the position to 708,293 shares worth $7.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1717.

BNP Paribas Financial Markets first reported a position in NVCR in Q4 2015 and has held it in 42 quarters since. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • BNP Paribas Financial Markets held 708,293 shares of NovoCure worth $7.72M as of Q1 2026.
  • BNP Paribas Financial Markets bought 464,221 NovoCure shares in Q1 2026, an estimated $5.8M.
  • NovoCure made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #1717 holding.
  • BNP Paribas Financial Markets first reported a position in NovoCure in Q4 2015 and has held it in 42 quarters since.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.